Shares of Trinity Biotech climbed after the company released what it called compelling results from a study of its next-generation continuous glucose monitoring system, a device used for diabetes ...
Blood glucose monitoring systems (BGMS) play a crucial role in the management of diabetes, allowing patients to track their blood sugar levels and make informed decisions about their treatment.
The global patient monitoring market size was valued at USD 55.60 billion in 2024 and is projected to reach from USD 59.66 billion in 2025 to USD 112.47 billion by 2033, growing at a CAGR of 7.3% ...